173 related articles for article (PubMed ID: 8692530)
61. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
Ali NN; Rowe J; Teich NM
J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
[TBL] [Abstract][Full Text] [Related]
62. Blood-borne biomarkers of osteosarcoma: A systematic review.
Tan GJS; Gerrand CH; Rankin KS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27462. PubMed ID: 30251311
[TBL] [Abstract][Full Text] [Related]
63. Correlation between prognostic factors and blood variables in osteosarcoma.
Broström LA; Ingimarsson S; Strander H; Eklund G
Acta Med Scand; 1980; 207(5):429-31. PubMed ID: 6930152
[TBL] [Abstract][Full Text] [Related]
64. Randomized, crossover comparison study of the short-term effect of oral testosterone undecanoate and intramuscular testosterone depot on linear growth and serum bone alkaline phosphatase.
Ahmed SF; Tucker P; Mayo A; Wallace AM; Hughes IA
J Pediatr Endocrinol Metab; 2004 Jul; 17(7):941-50. PubMed ID: 15301041
[TBL] [Abstract][Full Text] [Related]
65. Serum bone alkaline phosphatase in the follow-up of skeletal metastases.
Zaninotto M; Secchiero S; Rubin D; Sciacovelli L; Trovò M; Bortolus R; Plebani M
Anticancer Res; 1995; 15(5B):2223-8. PubMed ID: 8572629
[TBL] [Abstract][Full Text] [Related]
66. Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.
Milinković NL; Majkic-Singh NT; Ignjatović SD; Lezaić VD; Pejanović SD; Jovanovic DB
Clin Lab; 2012; 58(7-8):747-53. PubMed ID: 22997975
[TBL] [Abstract][Full Text] [Related]
67. Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma.
Bhudhisawasdi V; Muisuk K; Areejitranusorn P; Kularbkaew C; Khampitak T; Saeseow OT; Wongkham S
J Cancer Res Clin Oncol; 2004 Feb; 130(2):87-92. PubMed ID: 14648209
[TBL] [Abstract][Full Text] [Related]
68. Heme oxygenase-1 in osteosarcoma.
Kharb S; Halder M; Kundu ZS
J Cancer Res Ther; 2020; 16(4):874-877. PubMed ID: 32930133
[TBL] [Abstract][Full Text] [Related]
69. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation.
Avbersek-Luznik I; Gmeiner Stopar T; Marc J
Clin Chem Lab Med; 2007; 45(8):1014-8. PubMed ID: 17579570
[TBL] [Abstract][Full Text] [Related]
70. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
71. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data.
Ren HY; Sun LL; Li HY; Ye ZM
Biomed Res Int; 2015; 2015():160835. PubMed ID: 26618165
[TBL] [Abstract][Full Text] [Related]
72. High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma.
Yu W; Tang L; Lin F; Yao Y; Shen Z; Zhou X
Surg Oncol; 2015 Mar; 24(1):9-15. PubMed ID: 25453577
[TBL] [Abstract][Full Text] [Related]
73. Prognostic factors among 130 patients with osteosarcoma.
Pochanugool L; Subhadharaphandou T; Dhanachai M; Hathirat P; Sangthawan D; Pirabul R; Onsanit S; Pornpipatpong N
Clin Orthop Relat Res; 1997 Dec; (345):206-14. PubMed ID: 9418642
[TBL] [Abstract][Full Text] [Related]
74. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
75. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
[TBL] [Abstract][Full Text] [Related]
76. A retrospective study on craniofacial fibrous dysplasia: preoperative serum alkaline phosphatase as a prognostic marker?
Ma J; Liang L; Gu B; Zhang H; Wen W; Liu H
J Craniomaxillofac Surg; 2013 Oct; 41(7):644-7. PubMed ID: 23391394
[TBL] [Abstract][Full Text] [Related]
77. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.
Flores RJ; Kelly AJ; Li Y; Chen X; McGee C; Krailo M; Barkauskas DA; Hicks J; Man TK
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28544777
[TBL] [Abstract][Full Text] [Related]
78. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
Haarhaus M; Fernström A; Magnusson M; Magnusson P
Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
[TBL] [Abstract][Full Text] [Related]
79. Tumor-associated trypsin inhibitor (TATI) in bone diseases.
Rapellino M; Pecchio F; Broggi S; Baldi C; Ricardi G; Libertucci D
Scand J Clin Lab Invest Suppl; 1991; 207():65-6. PubMed ID: 1780696
[TBL] [Abstract][Full Text] [Related]
80. Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.
Holmes KE; Thompson V; Piskun CM; Kohnken RA; Huelsmeyer MK; Fan TM; Stein TJ
Vet Comp Oncol; 2015 Sep; 13(3):166-75. PubMed ID: 23489774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
